Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026

AAPG vs VBIX: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

VBIX Wins Head-to-Head Institutional Verdict (2–2 across 6 Pillars · 5–5 Matrix Metrics)

VBIX Overall Winner 6-Pillar Tally: AAPG 2 – 2 VBIX (2 Tie) Matrix Metrics: AAPG 5 – 5 VBIX

As of Nov 20, 2026, VBIX (VBIX) is the stronger overall head-to-head candidate over Ascentage Pharma Group International American Depository Shares (AAPG) in the Tradestie Institutional Equity Comparison Engine, winning 5–5 core matrix metrics and 2–2 across our 6-pillar institutional scorecard (led by Profitability & Quality, Balance Sheet & Cash Flow). AAPG carries a Unified Composite Score of 37.1/100 (SELL) at $11.97 (8.4x Forward P/E, -219.5% operating margin), whereas VBIX carries 53.0/100 (HOLD) at $3.64 (N/M Forward P/E, -139.2% operating margin).

  • Growth vs. Quality Trade-Off: VBIX earns the overall head-to-head edge with a stronger Unified Composite Score (53.0/100 HOLD vs. AAPG 37.1/100 SELL) and -0.08β · 98% Vol risk profile, whereas AAPG leads top-line expansion (+29.3% YoY revenue growth, N/M PEG, and 2 of 6 institutional pillars) for higher-beta growth mandates.
  • Technical & Structure Timing Caution: AAPG is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 28.8); meanwhile VBIX trades in a Markup technical trend (UNCLASSIFIED options phase, RSI 88.1). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About AAPG vs VBIX
AAPG NASDAQ
Ascentage Pharma Group International American Depository Shares
Pharmaceutical Preparations
$11.97
-3.78% 1D
Market Cap $1.2B
TTM Revenue $643M
Forward P/E 8.4x
Beta / 30D Vol 1.36β · 64% Vol
Unified Composite Score
37.1 / 100 SELL
Tech 25.0 Fund 42.0 Flow 50.0 Mom 55.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -7.6%), weak momentum, RSI 29
RSI-14: 28.8 · SMA20: $14.33 · SMA50: $14.97
VBIX US Equity Head-to-Head Winner
VBIX
Institutional Equity
$3.64
+20.13% 1D
Market Cap $40.4M
TTM Revenue $1.6M
Forward P/E N/M
Beta / 30D Vol -0.08β · 98% Vol
Unified Composite Score
53.0 / 100 HOLD
Tech 60.0 Fund 53.0 Flow 50.0 Mom 44.0
Weinstein Technical Phase Markup · Hold / add on dips
Price above SMA50, rising 50-day trend (12.1% over 20 days), RSI 88
RSI-14: 88.1 · SMA20: $2.38 · SMA50: $2.02

6-Pillar Scorecard Institutional Category Breakdown (AAPG 2 – 2 VBIX)

Columns: Metric · AAPG · VBIX
1. Valuation Multiples AAPG
Forward P/E 8.4x N/M
Trailing P/E 8.4x N/M
PEG Ratio N/M N/M
EV / Revenue 1.8x 26.1x
2. Growth & Scale AAPG
Revenue Growth (YoY) +29.3% -56.7%
Earnings Growth (YoY) +0.0% +0.0%
TTM Revenue (USD) $643M $1.6M
Market Cap $1.2B $40.4M
3. Profitability & Quality VBIX
Gross Margin 93.9% 81.1%
Operating Margin -219.5% -139.2%
Net Profit Margin -228.5% 0.0%
Return on Equity (ROE) -236.6% -214.4%
4. Balance Sheet & Cash Flow VBIX
Cash Generation (TTM) -$1.34B EBITDA -$3.0M
Cash Flow Margin N/A N/A
Net Cash / Leverage $0.89 Book/Sh · -236.6% ROE $512,000 Net Debt (0.11x D/E)
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning Tie
Options Structure Phase UNCLASSIFIED UNCLASSIFIED
Current IV / %ile N/A (N/A) N/A (N/A)
Put/Call OI Skew Thin ADR Chain N/A
OBV Trend / Tech Phase NEUTRAL · Markdown NEUTRAL · Markup
6. R&D & Supply-Chain Moat Tie
OpEx & R&D Intensity N/A N/A
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Cyclical / Execution-Driven Positioning
Supply-Chain Role Biotechnology Operator Internet Content & Information Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: AAPG (5) vs VBIX (5)
Institutional Metric AAPG VBIX Criterion Row Edge
Market Capitalization
Scale
$1.2B $40.4M Larger Scale AAPG
Trailing P/E Ratio
Valuation
8.4x N/M Lower Multiple AAPG
Forward P/E Ratio
Valuation
8.4x N/M Lower Multiple AAPG
Revenue Growth (YoY)
Growth
+29.3% -56.7% Higher Growth AAPG
Operating Margin (TTM)
Profitability
-219.5% -139.2% Higher Margin VBIX
Net Profit Margin
Profitability
-228.5% 0.0% Higher Margin VBIX
Return on Equity (ROE)
Capital Efficiency
-236.6% -214.4% Higher ROE VBIX
52-Week Range Position
Momentum
0% ($12–$34) 30% ($1–$10) Stronger Trend VBIX
Beta / 30D Volatility
Risk Regime
1.36β · 64% Vol -0.08β · 98% Vol Lower Realized Risk AAPG
Unified Institutional Score
Composite Signal
37.1 / 100 (SELL) 53.0 / 100 (HOLD) Higher Composite VBIX
Trailing 12M Revenue (USD)
Operating Scale
$643M $1.6M FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
93.9% 81.1% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · 1.8x EV/Rev N/M PEG · 26.1x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
-$1.34B EBITDA ($0.89 Book/Sh · -236.6% ROE) -$3.0M ($512,000 Net Debt (0.11x D/E)) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon VBIX +84.89 pp
AAPG: -2.89% · VBIX: +82.0%
3M Horizon VBIX +106.79 pp
AAPG: -14.2% · VBIX: +92.59%
6M Horizon VBIX +37.9 pp
AAPG: -32.39% · VBIX: +5.51%
1Y Horizon VBIX +37.9 pp
AAPG: -32.39% · VBIX: +5.51%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on AAPG vs VBIX. Trailing 12-month operating profitability (AAPG -219.5% vs VBIX -139.2%) and valuation multiples (AAPG 8.4x vs VBIX N/M Forward P/E) are benchmarked directly in Pillar 4 below.

AAPG ADR TTM Benchmark FX-Normalized USD
TTM Revenue$643M
Gross Margin93.9%
Op. Margin-219.5%
ROE / Fwd P/E-236.6% · 8.4x
VBIX ADR TTM Benchmark FX-Normalized USD
TTM Revenue$1.6M
Gross Margin81.1%
Op. Margin-139.2%
ROE / Fwd P/E-214.4% · N/M

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
AAPG UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew Thin ADR Chain
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact AAPG Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
VBIX UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact VBIX Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
AAPG Moat Profile Cyclical / Execution-Driven Positioning
Biotechnology Operator
Competes within the Biotechnology value chain with $1.2B market capitalization and -219.5% operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published
VBIX Moat Profile Cyclical / Execution-Driven Positioning
Internet Content & Information Operator
Competes within the Internet Content & Information value chain with $40.4M market capitalization and -139.2% operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published

Investor FAQ AAPG vs VBIX Key Questions & Quantitative Answers

As of Nov 20, 2026, VBIX (VBIX) is the stronger overall head-to-head candidate over Ascentage Pharma Group International American Depository Shares (AAPG) in the Tradestie Institutional Equity Comparison Engine, winning 5–5 core matrix metrics and 2–2 across our 6-pillar institutional scorecard (led by Profitability & Quality, Balance Sheet & Cash Flow). AAPG carries a Unified Composite Score of 37.1/100 (SELL) at $11.97 (8.4x Forward P/E, -219.5% operating margin), whereas VBIX carries 53.0/100 (HOLD) at $3.64 (N/M Forward P/E, -139.2% operating margin). Growth vs. Quality Trade-Off: VBIX earns the overall head-to-head edge with a stronger Unified Composite Score (53.0/100 HOLD vs. AAPG 37.1/100 SELL) and -0.08β · 98% Vol risk profile, whereas AAPG leads top-line expansion (+29.3% YoY revenue growth, N/M PEG, and 2 of 6 institutional pillars) for higher-beta growth mandates. Technical & Structure Timing Caution: AAPG is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 28.8); meanwhile VBIX trades in a Markup technical trend (UNCLASSIFIED options phase, RSI 88.1). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

AAPG leads the Growth & Scale pillar: AAPG posts +29.3% YoY revenue growth and +0.0% YoY earnings growth on $643M TTM revenue (93.9% gross margin, -219.5% operating margin), compared with VBIX at -56.7% YoY revenue growth and +0.0% YoY earnings growth on $1.6M TTM revenue (81.1% gross margin, -139.2% operating margin). On trailing 12-month operating scale, AAPG generates $643M in USD-normalized revenue versus $1.6M for VBIX. In operating R&D and SG&A reinvestment, AAPG deploys N/A (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for VBIX.

AAPG screens cheaper on headline valuation multiples. AAPG trades at 8.4x Forward P/E, 8.4x Trailing P/E, N/M PEG, and 1.8x EV/Revenue (unreported EBITDA margin), whereas VBIX trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and 26.1x EV/Revenue (unreported FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against AAPG (-236.6% ROE) versus VBIX (-214.4% ROE) capital efficiency.

In options market volatility and institutional positioning, AAPG carries N/A implied volatility (N/A, Unclassified), thin ADR options open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (1.36β · 64% Vol realized risk). By comparison, VBIX carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (-0.08β · 98% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 20, 2026. For educational research only; not investment advice.